Genetic predisposition does not predict exact medication response, but may help personalize expectations and monitoring strategies
[ Links ] Joca SR, Guimares FS (2006) Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects
DAY 2 Session 5: Device Design, User Interface, Human Factors, and Quality Format: Presentations and a Panel Discussion with Q&A (Virtual and In-Person Attendees) This session examines how device user interface differences in GLP-1 products affect substitutability, bioequivalence, and FDA expectations for Comparative analyses (CA) and Comparative Use Human Factors (CUHF) studies, and addresses device engineering and drug-device compatibility considerations that impact performance, bioequivalence, and ANDA review for GLP-1 generic combination products
10.1016/j.jtemb.2018.04.013 J
"AOD9604, a synthetic analogue of the lipolytic domain of human growth hormone, reduces body weight in obese subjects." International Journal of Obesity, vol
Gaillard R., Durmu B., Hofman A., Mackenbach J.P., Steegers E.A.P., Jaddoe V.W.V Risk factors and outcomes of maternal obesity and excessive weight gain during pregnancy